Genematrix
본문 바로가기
메인메뉴
전체메뉴열기
Product
하위분류
Molecular diagnosis
Biochemical diagnosis
Technology
하위분류
Technology
patent and paper
the new law
Genematrix
하위분류
Company introduction
Greeting
Network
Recruitment of human resources
directions
IR
Customer Support
하위분류
Inquire
Data room
PR
하위분류
news
Society, exhibition
Notice
전체메뉴
Product
Molecular diagnosis
Biochemical diagnosis
Technology
Technology
patent and paper
the new law
Genematrix
Company introduction
Greeting
Network
Recruitment of human resources
directions
IR
Customer Support
Inquire
Data room
PR
news
Society, exhibition
Notice
Product
Technology
Genematrix
Customer Support
PR
ENG
KOR
JPN
ESP
ARE
POR
Product
Molecular Diagnostics
Biochemical Diagnostics
Technology
Molecular Diagnostics
New Therapeutics Development
Patents and Publications
Genematrix
Company
Greeting
History
Recruitment of Human Resources
IR
Directions
Customer Support
Inquiry
Downloads
PR
Notice
News
Academics and Exhibitions
ENG
KOR
JPN
ESP
ARE
POR
Product
Molecular Diagnostics
Biochemical Diagnostics
Technology
Molecular Diagnostics
New Therapeutics Development
Patents and Publications
Genematrix
Company
Greeting
History
Recruitment of Human Resources
IR
Directions
Customer Support
Inquiry
Downloads
PR
Notice
News
Academics and Exhibitions
Home > Genematrix > History
HISTORY
COMPANY
GREETING
HISTORY
RECRUITMENT
IR
DIRECTIONS
COMPANY>
GREETING>
HISTORY>
RECRUITMENT>
IR>
DIRECTIONS>
HISTORY
Genematrix
(2000 ~ Present)
2020
Export license for COVID-19 diagnostic kit 'NeoPlex™ FluCOVID-19 Detection Kit'
Concluded contract with UNICEF to supply COVID-19 diagnostic kit
Patent application for new technology based on T-cell immunotherapy
COVID-19 diagnostic kit 'NeoPlex™ COVID-19 Detection Kit’ approved by US FDA for emergency use
Respiratory diagnostic product 'NeoPlex™ RV-panal A Detection Kit’ approved by the Ministry of Food and Drug Safety
Obtained permission to export COVID-19 diagnostic kit 'NeoPlex™ COVID-19 Detection Kit’
Digestive organs diagnosis product 'NeoPlex™ GI-virus 6 Detection Kit’ approved by the Ministry of Food and Drug Safety
2019
Respiratory diagnostic product 'NeoPlex™ RV-panel A Detection Kit’ granted European CE certification
Obtained patent for the composition of viral coat protein and zika protein production
Merged with Genematrix Bio Co., Ltd.
Respiratory disease causative bacteria diagnosis product 'NeoPlex™ RB-8 Detection Kit’ approved by the Ministry of Food and Drug Safety
C-TAG technology patent registration (10-1961642)
2018
£4 million investment in UK vaccine development company (Vaccitech Limited)
Sexually transmitted disease diagnosis product 'Neoplex STI-12’ approved by the Ministry of Food and Drug Safety
2017
Granted CE certification for sexually transmitted disease diagnosis product 'Neoplex STI-7’
CE certification for molecular diagnosis software 'Neoplex Viewer’
Selected as an excellent brain competency company (2017 K-Brainpower) (Ministry of Commerce, Industry and Energy)
Sexually transmitted pathogen multi-diagnosis product (Neoplex STI-7) approved by the Ministry of Food and Drug Safety
Registered patent for 'Method for Sequencing the Target Site of a Gene' (10-1738596)
New product for cervical cancer diagnosis (OmniPlex-HPV) approved by the Ministry of Food and Drug Safety
2016
Concluded contract for Zika Virus Vaccine Candidate Material Development and Efficacy Evaluation System Construction Service Project.
Registered European patent for 'Amplification Method for Genes with Various Mutations’
2014
HBV Entekabier Entrance New Medical Technology Registered
Patent for natural-derived anti-cancer drugs
Kim Soo-ok took office as CEO
2013
KFDA item authorization for eight in vitro medical devices
Papillotyper, CE certified
Development of HIV-tailored Treatment Diagnostics
2012
Enter organic certification business
Headquarters relocation (Korea Bio Park)
2011
Acquisition of HBI, a venture company specializing in diagnostic drugs
Development of hepatotyper for early diagnosis of liver cancer
2010
Cross license agreement with Riversense, USA
Received the Presidential commendation for venture company
2009
Earned the RFMP certification (US 7,541,148)
Supervised International Joint Research and Development Project by the Ministry of Knowledge Economy
Listed on KOSDAQ
2008
Publication in Nature Protocols
Selected as a national new growth-engine industry
2007
Confirmed for Innovation Business (Inno-Biz)
Received the GSK Hepatitis Academic Award (Korean Association for the Study of the Liver)
Received the Patent Grand Prize, King Sejong Award (Korean Intellectual Property Office)
2006
Awarded the Grand Prize at the Asian Pacific Association for the Study of the Liver
Publication in Gastroenterology
Publication in Gut
Publication in Hepatology
2005
Patent registered for RFMP technology in Korea (No. 477766)
Received the GSK Hepatitis Academic Award (Korean Association for the Study of the Liver)
Selected as one of the Top 100 Successful Industrial Technology Development Projects
2003
RFMP Technology Licensing Out (Clinical Genotyping Technology)
Joint core technology development projects of the Ministry of Commerce Industry and Energy (Virus molecular diagnostics)
2002
Health and medical development projects of the Ministry of Health and Welfare
Common food technology development business of the Ministry of Commerce Industry and Energy
Development of drug resistant viral genetic analysis for hepatitis therapy
2001
Establishment of an affiliated research institute (within the Institute of Cancer Research, Seoul National University College of Medicine)
Strategic alliance with Variagenics, USA (Development of Genetic Marker in Pathway of Drug Action)
Certified venture business (New technology)
Certified as the venture business (New technology)
2000
Establishment of Genematrix, Inc.
회원
로그인
회원가입
회원아이디
필수
비밀번호
필수
자동로그인
정보찾기